Initial survival outcomes for the AGITG GAP study ��� a phase II study of perioperative nab -paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC).

Digital Object Identifier (doi)

• 10.1200/jco.2016.34.15_suppl.4105

Web Of Science Accession Number

Start Page

• 4105

End Page

• 4105

Volume

• 34

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   Aghmesheh, Morteza (external author)

Publication Date

• 2016

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Digital Object Identifier (doi)

• 10.1200/jco.2016.34.15_suppl.4105

Web Of Science Accession Number

Start Page

• 4105

End Page

• 4105

Volume

• 34

Issue

• 15_suppl

Place Of Publication